Biotechnology Assets S.A. (BST) — Cash Flow-to-Debt Ratio
Biotechnology Assets S.A. (BST) has a Cash Flow-to-Debt Ratio of 0.09x as of June 2025, meaning its operating cash flow of €658.13K could theoretically repay 0% of its total liabilities (€7.01 Million) in one year. See BST free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Biotechnology Assets S.A. Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for Biotechnology Assets S.A. across 11 annual periods. Also explore net asset momentum of Biotechnology Assets S.A. to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Biotechnology Assets S.A. (2014–2024)
Year-by-year debt coverage analysis for Biotechnology Assets S.A.. For market capitalisation and broader financial context, see market value of Biotechnology Assets S.A..
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.01x | €-73.85K | €8.17 Million | ▼ -290.7% |
| 2023 | 0.00x | €47.74K | €10.08 Million | ▲ +104.0% |
| 2022 | -0.12x | €-1.73 Million | €14.60 Million | ▼ -22.8% |
| 2021 | -0.10x | €-1.50 Million | €15.54 Million | ▼ -118.0% |
| 2020 | 0.54x | €8.79 Million | €16.37 Million | ▲ +401.6% |
| 2019 | -0.18x | €-15.16 Million | €85.11 Million | ▲ +20.6% |
| 2018 | -0.22x | €-13.02 Million | €58.04 Million | ▼ -1104.4% |
| 2017 | 0.02x | €213.49K | €9.56 Million | ▼ -93.4% |
| 2016 | 0.34x | €2.71 Million | €8.02 Million | ▲ +1447.8% |
| 2015 | 0.02x | €158.16K | €7.23 Million | ▲ +150.5% |
| 2014 | -0.04x | €-303.79K | €7.01 Million | — |